Share Price and Basic Stock Data
Last Updated: February 16, 2026, 9:19 pm
| PEG Ratio | 0.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alankit Ltd operates in the Finance & Investments sector, with a current market capitalization of ₹246 Cr and a share price of ₹9.12. The company’s revenue trajectory has been volatile, with sales recorded at ₹312 Cr for the fiscal year ending March 2023, a significant rise from ₹128 Cr in March 2022. However, the latest figures for the trailing twelve months (TTM) show a modest increase to ₹346 Cr. Quarterly sales indicate fluctuations, peaking at ₹148.18 Cr in March 2023, but subsequently declining to ₹43.32 Cr in September 2023. This inconsistency suggests challenges in maintaining stable revenue streams, which could be a concern for investors. The company’s operating profit margin (OPM) has also shown variability, standing at just 4.27% currently, indicating a need for improved cost management to enhance profitability. The reported sales figures illustrate the company’s struggle to achieve consistent growth, which may affect future investor confidence.
Profitability and Efficiency Metrics
Alankit Ltd has reported a net profit of ₹21 Cr, translating to a return on equity (ROE) of 7.56% and a return on capital employed (ROCE) of 11.3%. While these figures reflect a reasonable return on investment, they remain below the expectations in the finance sector, where higher ROE and ROCE are typically favored. The interest coverage ratio (ICR) stands at a robust 13.34x, indicating strong capacity to cover interest obligations, which is a positive aspect of the company’s financial health. However, the operating profit margin of 4.27% indicates that the company is not fully capitalizing on its sales, necessitating strategic initiatives to enhance operational efficiency. Additionally, the cash conversion cycle (CCC) of 35 days is relatively efficient, suggesting that the company effectively manages its receivables and payables. Overall, while profitability metrics show some strength, there are areas that require substantial improvement to align with industry benchmarks.
Balance Sheet Strength and Financial Ratios
Alankit Ltd’s balance sheet reflects a cautious approach to borrowing, with total borrowings recorded at ₹21 Cr against reserves of ₹280 Cr. This results in a low debt-to-equity ratio of 0.03, indicating a conservative capital structure that minimizes financial risk. The company’s current ratio stands at 2.16, suggesting strong liquidity, while the quick ratio of 2.08 reinforces the company’s ability to meet short-term obligations. The price-to-book value (P/BV) ratio is currently at 1.26x, indicating that the stock is trading slightly above its book value, which may be perceived as a fair valuation by the market. Furthermore, the enterprise value (EV) to net operating revenue ratio of 1.26x is in line with typical sector ranges, suggesting that the company is valued reasonably in relation to its revenue generation capabilities. Overall, the balance sheet demonstrates strength, although the relatively low profitability ratios may limit overall valuation appeal.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alankit Ltd indicates a strong promoter presence, with promoters holding 54.14% of the shares. This level of control may enhance investor confidence, as it reflects commitment from those closely associated with the company’s operations. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minimal stakes, at 0.37% and 0.01%, respectively, which may raise concerns about broader institutional interest in the company. The public shareholding stands at 45.47%, with the number of shareholders increasing to 114,068, reflecting growing retail investor interest. Nevertheless, the lack of significant institutional investment might suggest hesitance regarding the company’s growth prospects. The investor sentiment is mixed, with strong promoter backing juxtaposed against limited institutional involvement, highlighting a potential area for Alankit to address in order to bolster market confidence.
Outlook, Risks, and Final Insight
Alankit Ltd faces a mixed outlook characterized by both opportunities and risks. On the positive side, the company’s low debt levels and strong interest coverage ratio position it well to navigate potential economic downturns. However, the inconsistency in revenue growth and profitability metrics poses significant risks. The volatile quarterly sales figures may indicate challenges in sustaining customer demand or competition within the finance sector. Additionally, the limited institutional investment could hinder the company’s ability to leverage broader market support for growth initiatives. Moving forward, Alankit Ltd must focus on stabilizing its revenue streams and improving operational efficiency to enhance profitability. If the company can successfully execute these strategies, it may attract further institutional interest and strengthen its market position. Conversely, failure to address these operational challenges could limit growth and investor confidence in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 10.9 Cr. | 37.3 | 53.0/32.5 | 52.1 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,326 Cr. | 292 | 399/265 | 14.5 | 111 | 0.34 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 30.9 Cr. | 0.44 | 0.90/0.38 | 4.94 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 3.94 Cr. | 7.96 | 11.5/7.58 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 14.6 Cr. | 28.4 | 69.9/24.5 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,281.83 Cr | 1,242.37 | 108.30 | 4,366.08 | 0.38% | 21.71% | 14.20% | 7.23 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.19 | 116.10 | 148.18 | 48.62 | 43.32 | 52.61 | 91.16 | 61.93 | 64.35 | 72.77 | 102.01 | 90.78 | 80.09 |
| Expenses | 27.86 | 105.15 | 139.92 | 43.26 | 38.70 | 49.05 | 80.79 | 53.72 | 58.94 | 66.14 | 89.53 | 95.33 | 76.67 |
| Operating Profit | -14.67 | 10.95 | 8.26 | 5.36 | 4.62 | 3.56 | 10.37 | 8.21 | 5.41 | 6.63 | 12.48 | -4.55 | 3.42 |
| OPM % | -111.22% | 9.43% | 5.57% | 11.02% | 10.66% | 6.77% | 11.38% | 13.26% | 8.41% | 9.11% | 12.23% | -5.01% | 4.27% |
| Other Income | -36.85 | -6.81 | 2.08 | 2.45 | 2.47 | 5.76 | 1.16 | 3.11 | 3.85 | 1.95 | 3.52 | 16.93 | 5.58 |
| Interest | 0.49 | 0.52 | 0.13 | 0.25 | 0.60 | 0.56 | -0.29 | 0.86 | 0.95 | 0.97 | 1.05 | 0.59 | 0.84 |
| Depreciation | 1.90 | 1.97 | 2.47 | 1.94 | 1.91 | 1.88 | 1.94 | 1.90 | 2.16 | 2.77 | 3.56 | 3.27 | 3.31 |
| Profit before tax | -53.91 | 1.65 | 7.74 | 5.62 | 4.58 | 6.88 | 9.88 | 8.56 | 6.15 | 4.84 | 11.39 | 8.52 | 4.85 |
| Tax % | -7.81% | -161.21% | 27.52% | 13.70% | 44.54% | -18.02% | 34.62% | 12.03% | 40.49% | -7.44% | 53.73% | 30.05% | 7.42% |
| Net Profit | -49.69 | 4.31 | 5.60 | 4.85 | 2.54 | 8.12 | 6.47 | 7.53 | 3.67 | 5.20 | 5.27 | 5.96 | 4.49 |
| EPS in Rs | -3.24 | 0.24 | 0.21 | 0.21 | 0.09 | 0.36 | 0.24 | 0.27 | 0.12 | 0.19 | 0.16 | 0.19 | 0.16 |
Last Updated: January 2, 2026, 1:34 pm
Below is a detailed analysis of the quarterly data for Alankit Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 80.09 Cr.. The value appears to be declining and may need further review. It has decreased from 90.78 Cr. (Jun 2025) to 80.09 Cr., marking a decrease of 10.69 Cr..
- For Expenses, as of Sep 2025, the value is 76.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 95.33 Cr. (Jun 2025) to 76.67 Cr., marking a decrease of 18.66 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.42 Cr.. The value appears strong and on an upward trend. It has increased from -4.55 Cr. (Jun 2025) to 3.42 Cr., marking an increase of 7.97 Cr..
- For OPM %, as of Sep 2025, the value is 4.27%. The value appears strong and on an upward trend. It has increased from -5.01% (Jun 2025) to 4.27%, marking an increase of 9.28%.
- For Other Income, as of Sep 2025, the value is 5.58 Cr.. The value appears to be declining and may need further review. It has decreased from 16.93 Cr. (Jun 2025) to 5.58 Cr., marking a decrease of 11.35 Cr..
- For Interest, as of Sep 2025, the value is 0.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.59 Cr. (Jun 2025) to 0.84 Cr., marking an increase of 0.25 Cr..
- For Depreciation, as of Sep 2025, the value is 3.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.27 Cr. (Jun 2025) to 3.31 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.85 Cr.. The value appears to be declining and may need further review. It has decreased from 8.52 Cr. (Jun 2025) to 4.85 Cr., marking a decrease of 3.67 Cr..
- For Tax %, as of Sep 2025, the value is 7.42%. The value appears to be improving (decreasing) as expected. It has decreased from 30.05% (Jun 2025) to 7.42%, marking a decrease of 22.63%.
- For Net Profit, as of Sep 2025, the value is 4.49 Cr.. The value appears to be declining and may need further review. It has decreased from 5.96 Cr. (Jun 2025) to 4.49 Cr., marking a decrease of 1.47 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.16. The value appears to be declining and may need further review. It has decreased from 0.19 (Jun 2025) to 0.16, marking a decrease of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3 | 31 | 85 | 105 | 130 | 156 | 115 | 128 | 312 | 236 | 301 | 346 |
| Expenses | 3 | 22 | 64 | 76 | 110 | 132 | 96 | 117 | 299 | 210 | 268 | 328 |
| Operating Profit | -1 | 9 | 21 | 29 | 21 | 24 | 19 | 11 | 13 | 26 | 33 | 18 |
| OPM % | -27% | 28% | 25% | 28% | 16% | 15% | 17% | 9% | 4% | 11% | 11% | 5% |
| Other Income | 2 | 0 | 2 | 4 | 8 | 7 | 3 | 9 | -40 | 12 | 12 | 28 |
| Interest | 0 | 0 | 1 | 3 | 2 | 3 | 4 | 3 | 2 | 3 | 4 | 3 |
| Depreciation | 0 | 3 | 1 | 4 | 4 | 5 | 4 | 9 | 8 | 8 | 10 | 13 |
| Profit before tax | 1 | 5 | 20 | 26 | 22 | 23 | 15 | 8 | -38 | 27 | 31 | 30 |
| Tax % | 64% | 29% | 35% | 16% | 35% | 38% | 24% | 66% | -8% | 19% | 30% | |
| Net Profit | 0 | 4 | 13 | 22 | 14 | 14 | 11 | 3 | -35 | 22 | 22 | 21 |
| EPS in Rs | 0.03 | 0.26 | 0.93 | 1.52 | 0.98 | 0.98 | 0.69 | 0.17 | -1.50 | 0.80 | 0.73 | 0.70 |
| Dividend Payout % | 193% | 39% | 22% | 13% | 20% | 20% | 29% | 121% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 225.00% | 69.23% | -36.36% | 0.00% | -21.43% | -72.73% | -1266.67% | 162.86% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -155.77% | -105.59% | 36.36% | -21.43% | -51.30% | -1193.94% | 1429.52% | -162.86% |
Alankit Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 61% |
| 5 Years: | 14% |
| 3 Years: | 33% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 52% |
| 5 Years: | 12% |
| 3 Years: | 110% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -6% |
| 3 Years: | 1% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| Last Year: | 8% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 22 | 27 | 27 | 27 |
| Reserves | 24 | 28 | 33 | 49 | 59 | 73 | 80 | 119 | 139 | 249 | 270 | 280 |
| Borrowings | 0 | 0 | 5 | 5 | 14 | 13 | 14 | 21 | 13 | 44 | 12 | 21 |
| Other Liabilities | 1 | 16 | 26 | 58 | 53 | 71 | 57 | 107 | 128 | 211 | 116 | 116 |
| Total Liabilities | 33 | 51 | 78 | 126 | 140 | 172 | 165 | 261 | 302 | 531 | 425 | 445 |
| Fixed Assets | 1 | 28 | 28 | 36 | 55 | 50 | 68 | 87 | 56 | 50 | 81 | 77 |
| CWIP | 0 | 0 | 0 | 18 | 16 | 18 | 1 | 0 | 0 | 9 | 0 | 0 |
| Investments | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 12 | 11 | 21 | 36 | 40 |
| Other Assets | 30 | 23 | 49 | 70 | 68 | 104 | 97 | 161 | 236 | 451 | 308 | 328 |
| Total Assets | 33 | 51 | 78 | 126 | 140 | 172 | 165 | 261 | 302 | 531 | 425 | 445 |
Below is a detailed analysis of the balance sheet data for Alankit Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 280.00 Cr.. The value appears strong and on an upward trend. It has increased from 270.00 Cr. (Mar 2025) to 280.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 12.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 116.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 116.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 445.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 425.00 Cr. (Mar 2025) to 445.00 Cr., marking an increase of 20.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 77.00 Cr.. The value appears to be declining and may need further review. It has decreased from 81.00 Cr. (Mar 2025) to 77.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 328.00 Cr.. The value appears strong and on an upward trend. It has increased from 308.00 Cr. (Mar 2025) to 328.00 Cr., marking an increase of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 445.00 Cr.. The value appears strong and on an upward trend. It has increased from 425.00 Cr. (Mar 2025) to 445.00 Cr., marking an increase of 20.00 Cr..
Notably, the Reserves (280.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | 9.00 | 16.00 | 24.00 | 7.00 | 11.00 | 5.00 | -10.00 | 0.00 | -18.00 | 21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106 | 69 | 54 | 49 | 78 | 89 | 110 | 131 | 80 | 111 | 72 |
| Inventory Days | 1,297 | 247 | 76 | 142 | 288 | 57 | 119 | 62 | 9 | 31 | 19 |
| Days Payable | 288 | 59 | 92 | 1,274 | 561 | 274 | 316 | 221 | 47 | 153 | 56 |
| Cash Conversion Cycle | 1,114 | 257 | 38 | -1,083 | -196 | -129 | -88 | -28 | 41 | -10 | 35 |
| Working Capital Days | 2,506 | 91 | 26 | 4 | 27 | 86 | 147 | 14 | 105 | -54 | 77 |
| ROCE % | 16% | 50% | 47% | 30% | 24% | 17% | 8% | 8% | 11% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.73 | 0.96 | -2.07 | 0.16 | 0.77 |
| Diluted EPS (Rs.) | 0.73 | 0.96 | -2.07 | 0.16 | 0.77 |
| Cash EPS (Rs.) | 1.18 | 1.09 | -1.19 | 0.80 | 1.08 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 10.94 | 10.95 | 8.07 | 10.12 | 6.88 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 10.94 | 10.95 | 8.07 | 10.12 | 6.88 |
| Revenue From Operations / Share (Rs.) | 11.10 | 8.69 | 13.88 | 8.96 | 8.04 |
| PBDIT / Share (Rs.) | 1.88 | 1.32 | 0.97 | 1.31 | 1.44 |
| PBIT / Share (Rs.) | 1.50 | 1.04 | 0.59 | 0.69 | 1.13 |
| PBT / Share (Rs.) | 1.14 | 0.99 | -1.71 | 0.58 | 1.02 |
| Net Profit / Share (Rs.) | 0.79 | 0.81 | -1.56 | 0.20 | 0.77 |
| NP After MI And SOA / Share (Rs.) | 0.73 | 0.79 | -1.50 | 0.16 | 0.77 |
| PBDIT Margin (%) | 16.96 | 15.17 | 7.00 | 14.56 | 17.91 |
| PBIT Margin (%) | 13.51 | 11.91 | 4.28 | 7.76 | 14.09 |
| PBT Margin (%) | 10.27 | 11.43 | -12.30 | 6.55 | 12.67 |
| Net Profit Margin (%) | 7.19 | 9.32 | -11.26 | 2.24 | 9.62 |
| NP After MI And SOA Margin (%) | 6.59 | 9.14 | -10.82 | 1.83 | 9.62 |
| Return on Networth / Equity (%) | 6.69 | 7.80 | -20.95 | 1.76 | 11.74 |
| Return on Capital Employeed (%) | 12.37 | 9.17 | 6.67 | 5.84 | 12.60 |
| Return On Assets (%) | 4.67 | 4.05 | -11.16 | 0.90 | 6.69 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.09 |
| Total Debt / Equity (X) | 0.03 | 0.15 | 0.08 | 0.15 | 0.14 |
| Asset Turnover Ratio (%) | 0.63 | 0.56 | 1.11 | 0.60 | 0.68 |
| Current Ratio (X) | 2.16 | 1.16 | 2.09 | 1.37 | 2.46 |
| Quick Ratio (X) | 2.08 | 1.13 | 2.04 | 1.26 | 2.34 |
| Inventory Turnover Ratio (X) | 42.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 121.32 | 25.81 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 25.84 | 18.48 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | -21.32 | 74.19 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 74.16 | 81.52 |
| Interest Coverage Ratio (X) | 13.34 | 31.83 | 13.43 | 11.95 | 12.61 |
| Interest Coverage Ratio (Post Tax) (X) | 8.21 | 20.57 | 10.20 | 2.84 | 7.78 |
| Enterprise Value (Cr.) | 379.17 | 477.53 | 180.29 | 198.90 | 237.14 |
| EV / Net Operating Revenue (X) | 1.26 | 2.03 | 0.57 | 1.55 | 2.06 |
| EV / EBITDA (X) | 7.42 | 13.35 | 8.26 | 10.66 | 11.51 |
| MarketCap / Net Operating Revenue (X) | 1.25 | 2.04 | 0.52 | 1.47 | 1.97 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | -21.32 | 74.18 |
| Price / BV (X) | 1.26 | 1.74 | 1.02 | 1.42 | 2.40 |
| Price / Net Operating Revenue (X) | 1.25 | 2.04 | 0.52 | 1.47 | 1.97 |
| EarningsYield | 0.05 | 0.04 | -0.20 | 0.01 | 0.04 |
After reviewing the key financial ratios for Alankit Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 0.96 (Mar 24) to 0.73, marking a decrease of 0.23.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 0.96 (Mar 24) to 0.73, marking a decrease of 0.23.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 3. It has increased from 1.09 (Mar 24) to 1.18, marking an increase of 0.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.94. It has decreased from 10.95 (Mar 24) to 10.94, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.94. It has decreased from 10.95 (Mar 24) to 10.94, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.10. It has increased from 8.69 (Mar 24) to 11.10, marking an increase of 2.41.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.88. This value is below the healthy minimum of 2. It has increased from 1.32 (Mar 24) to 1.88, marking an increase of 0.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.50, marking an increase of 0.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.14, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 2. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 2. It has decreased from 0.79 (Mar 24) to 0.73, marking a decrease of 0.06.
- For PBDIT Margin (%), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from 15.17 (Mar 24) to 16.96, marking an increase of 1.79.
- For PBIT Margin (%), as of Mar 25, the value is 13.51. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 13.51, marking an increase of 1.60.
- For PBT Margin (%), as of Mar 25, the value is 10.27. This value is within the healthy range. It has decreased from 11.43 (Mar 24) to 10.27, marking a decrease of 1.16.
- For Net Profit Margin (%), as of Mar 25, the value is 7.19. This value is within the healthy range. It has decreased from 9.32 (Mar 24) to 7.19, marking a decrease of 2.13.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.59. This value is below the healthy minimum of 8. It has decreased from 9.14 (Mar 24) to 6.59, marking a decrease of 2.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 15. It has decreased from 7.80 (Mar 24) to 6.69, marking a decrease of 1.11.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.37. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 12.37, marking an increase of 3.20.
- For Return On Assets (%), as of Mar 25, the value is 4.67. This value is below the healthy minimum of 5. It has increased from 4.05 (Mar 24) to 4.67, marking an increase of 0.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.15 (Mar 24) to 0.03, marking a decrease of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has increased from 0.56 (Mar 24) to 0.63, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.16 (Mar 24) to 2.16, marking an increase of 1.00.
- For Quick Ratio (X), as of Mar 25, the value is 2.08. This value exceeds the healthy maximum of 2. It has increased from 1.13 (Mar 24) to 2.08, marking an increase of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 42.21. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 42.21, marking an increase of 42.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.34. This value is within the healthy range. It has decreased from 31.83 (Mar 24) to 13.34, marking a decrease of 18.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 20.57 (Mar 24) to 8.21, marking a decrease of 12.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 379.17. It has decreased from 477.53 (Mar 24) to 379.17, marking a decrease of 98.36.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 2.03 (Mar 24) to 1.26, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 7.42. This value is within the healthy range. It has decreased from 13.35 (Mar 24) to 7.42, marking a decrease of 5.93.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.25, marking a decrease of 0.79.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.26, marking a decrease of 0.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.25, marking a decrease of 0.79.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alankit Ltd:
- Net Profit Margin: 7.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.37% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.69% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.5 (Industry average Stock P/E: 108.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 205-208, Anarkali Complex, New Delhi Delhi 110055 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Kumar Sinha | Chairman & Ind.Director |
| Mr. Ankit Agarwal | Managing Director |
| Mrs. Preeti Chadha | Non Executive Director |
| Mrs. Meera Lal | Non Executive Director |
| Mr. Raja Gopal Reddy Guduru | Non Executive Director |
| Ms. Meenu Agrawal | Independent Director |
FAQ
What is the intrinsic value of Alankit Ltd?
Alankit Ltd's intrinsic value (as of 17 February 2026) is ₹9.71 which is 6.47% higher the current market price of ₹9.12, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹246 Cr. market cap, FY2025-2026 high/low of ₹18.1/8.75, reserves of ₹280 Cr, and liabilities of ₹445 Cr.
What is the Market Cap of Alankit Ltd?
The Market Cap of Alankit Ltd is 246 Cr..
What is the current Stock Price of Alankit Ltd as on 17 February 2026?
The current stock price of Alankit Ltd as on 17 February 2026 is ₹9.12.
What is the High / Low of Alankit Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alankit Ltd stocks is ₹18.1/8.75.
What is the Stock P/E of Alankit Ltd?
The Stock P/E of Alankit Ltd is 10.5.
What is the Book Value of Alankit Ltd?
The Book Value of Alankit Ltd is 11.3.
What is the Dividend Yield of Alankit Ltd?
The Dividend Yield of Alankit Ltd is 0.00 %.
What is the ROCE of Alankit Ltd?
The ROCE of Alankit Ltd is 11.3 %.
What is the ROE of Alankit Ltd?
The ROE of Alankit Ltd is 7.56 %.
What is the Face Value of Alankit Ltd?
The Face Value of Alankit Ltd is 1.00.